Smartphones, artificial intelligence, automation, digital communication, and other types of technology are playing an increasingly important role in our daily lives. It is no surprise that technology is also shaping the practice of medicine, and more specifically the practice of genetic counseling.
responsibilities to families with guided questionnaires, implementing algorithms for risk calculation, generating differential diagnoses, facilitating documentation, and automating follow-up. In addition, it has the potential to help families and providers prioritize individuals who have the greatest need for genetic counseling, while also meeting the needs of families whose concerns are less acute or complex. Alternative technology such as videos and interactive tools informed by genetic counselors can assist in optimizing this model. These advances align with several initiatives of the precision health era, for which there is a growing need for genetic counseling. This article reviews the use of technology in historic and current genetic counseling practice and discusses challenges and future directions.
| H I STOR I CA L U SE S OF TE CH N OLOGY I N GE N ETI C COU N SEL I NG
The field of medical genetics and genomics is continually evolving, and genetic counselors are no strangers to adjusting and adapting their practices to meet changing needs. Technology offers tools that genetic counselors and other clinicians can use to make their work more efficient and effective. Although an explosion of innovations has recently entered the market, technological solutions and tools designed to assist genetic counseling practices have been available since the 1990s.
| Pedigree construction
A key component of genetic counseling in any specialty is documenting and analyzing a detailed medical pedigree. Initially, pedigrees were drawn by hand. However, plastic templates to draw standardized pedigree symbols (Bennett, French, Resta, & Doyle, 2008) became available in the 1990s to quicken the process. Experts in the genetic counseling field even recommended their use when educating others about how to take a pedigree (Bennett, 2010) .
Software companies soon offered applications, such as Cyrillic (McMahon, 1996 ; http://www.apbenson.com/about-cyrillic/) and Progeny (www.progenygenetics.com/about), which made the process paperless. Genetic counselors in clinical and research settings could take family history details directly from patients and enter it into an application before, during, or after an appointment. Some applications also captured patient clinical information, allowing for clinics and research programs to use it as a patient database. Numerous applications now exist for family history collection, some of which rely on data entry by the patient, freeing up time for genetic counselors to focus on analyzing the pedigree and assessing risks.
| Genetic risk analysis
Technology has further streamlined the process of pedigree risk analysis for genetic counselors and other clinicians, particularly within the specialty of cancer genetics. UT Southwestern's CancerGene (http://www4.utsouthwestern.edu/breasthealth/cagene/) emerged in 1998 as one of the first platforms for clinicians to electronically run the Gail and Claus risk models to assess a patient's lifetime risk to develop breast cancer and her/his risk of having a BRCA1/BRCA2 gene mutation (Claus, Schildkraut, Thompson, & Risch, 1996; Gail et al., 1989) .
More electronic risk models followed for hereditary breast-ovarian cancer, as well as for hereditary colorectal cancer, pancreatic cancer, and melanoma (Balmaña et al., 2006; Chen et al., 2006; Tyrer, Duffy, & Cuzick, 2004; Wang et al., 2007 Wang et al., , 2010 . Originally, clinicians in cancer genetics clinics were the primary users. Pedigree applications also began incorporating cancer risk modeling analysis, so clinicians in cancer genetics settings could document and analyze a pedigree efficiently, without multiple points of data entry. Increasingly, healthcare providers outside of genetics are using similar technology to identify patients at risk for hereditary cancer (Finkelstein, Wood, Crew, & Kukafka, 2017; Guerra, Sherman, & Armstrong, 2009 ).
| Online medical information collection and review
While the pedigree is a vital component of the medical history, genetic counselors also spend a great deal of time gathering other needed medical background for patients and family members. Historically, this occurred as a manual review of patient medical records and information that a family provided by phone or in person. Genetics clinics also mailed families forms to complete before a patient was seen, so a genetic counselor or medical geneticist could review them prior to the appointment. Slowly, genetics clinics began making their medical history forms available or fillable online, so patients could log on and securely submit their information. This allowed genetic counselors to more easily review the information and potentially merge details into their own documentation. The implementation of this technology also resulted in sooner appointments for families as the time required for mailing, receiving, and sorting of the paper intake forms was eliminated.
| Diagnostic evaluation
Application of technological tools to assist in developing a strong differential diagnosis also has precedent. Identification of the most likely genetic diagnosis for any given patient can be challenging, in part due to the increasing number of recognized disorders, varied clinical presentations, and relative rarity. Accurate genetic counseling hinges upon diagnostic differentials that, in the genetics clinic, medical geneticists and genetic counselors may determine together. For many years, technology has aided this process. SYNDROC, a microcomputer-based algorithm that generated differential diagnoses for dysmorphic syndromes (Schorderet & Aebischer, 1985) , was an early application of algorithm-driven technology. First released in 1987 in CD-ROM format, the Australian-based Pictures of Standard Syndromes and Undiagnosed Malformations (POSSUM) allowed genetics clinicians to search photographs and medical symptoms to refine diagnostic possibilities for their patients (Strømme, 1991) . The London Dysmorphology Database came out in 1990 as a similar tool (Bass, 2002) and after decades in book form, the Online Mendelian Inheritance in Man was first introduced as an online tool in 1987 (OMIM, 2018) . All impacted the practice of genetic counseling by increasing efficiency.
| Online medical documentation
Technology has also revolutionized medical records and documentation. In the setting of an electronic medical records system, genetic counselors can quickly review past medical history information and add their own documentation and evaluations to the medical record. Some computer applications, such as pedigree software programs, added the ability for genetic counselors and other clinicians to use templated consultation notes or letters with information pre-populated about the patient. This saves time and reduces the potential for error.
| C U RR EN T U SE S OF TE CH N OLOGY I N G EN ET I C COU N SEL I N G
Building upon the gradually adopted technological tools of the past, innovations in modern technology continue to play myriad roles in the practice of genetic counseling. These include increased availability of patient-focused educational aids, to new mechanisms for providing counseling to patients in remote locations, to tools for triaging patients appropriate for genetic counseling; each new application has a significant impact on providers and patients.
| Telemedicine
Telemedicine has been in use in genetic counseling for almost 20 years, since the first pilot study was done in 1998 in North Wales. The pilot project was a response to growing demand for genetic services in an area that previously had only periodic satellite clinics (Gray et al., 2000) . Since then, there have been numerous publications documenting high satisfaction rates among patients and providers using telemedicine, in areas including knowledge, satisfaction, and psychological variables such as distress and anxiety (Buchanan et al., 2016) . Concerns about telegenetics have been raised by providers, including the potential to miss non-verbal cues and inability to facilitate the same depth of patient-provider relationship as a face-to-face visit. In addition, logistic and administrative issues such as limited ability to conduct a physical exam, the need for licensure where the patient is physically located, and limitations on billing in some states create additional challenges.
However, telegenetics appears, by some patients and providers, to be an acceptable, if not preferable, alternative to in-person genetic counseling (Cohen, Huziak, Gustafson, & Grubs, 2016) . Given the benefits of allowing greater geographic reach of genetic services, decreased costs, time savings, and increased access, it is becoming increasingly popular. Both academic medical centers (e.g., UT Southwestern, University of Pennsylvania, etc.) and private practices (e.g., GeneMatters, Genome Medical, InformedDNA, Metis Genetics) have embraced or developed telemedicine services as an alternative service delivery model.
| Artificial intelligence-driven solutions
Artificial intelligence (AI) technology is being applied in medical genetics to assist and educate clinicians, patients, and health consumers in patient identification, and risk assessment, as well as aiding in making a Identifying at-risk patients and providing individualized education on a larger scale is further being revolutionized via technological advances in cognitive computing that use machine learning and natural language processing to help healthcare providers and patients. One widely publicized use of this technology is the IBM Watson based "Watson for Oncology" clinical decision-support system that pulls together the rapidly changing scientific evidence (including information on inherited susceptibility genes), drug approvals, and treatment guidelines in cancer and breast cancer to provide suggestions for treatment decision making in breast cancer (Somashekhar et al., 2018) . Another is the algorithmbased function of websites with genetics content, such as ThinkGenetic.com, to help offer users and patients individualized answers to their questions about genetic disease or risk.
Another application of AI is chatbots, applications that simulate conversations in the way people would naturally speak to one another.
Chatbots capitalize on natural language processing to automate textbased dialogues. This is the same technology used in increasingly common household items like the voice-activated digital personal assistants Google Home or Amazon Echo. Although relatively new to genetics, chat and text options have been well studied in the mental health arena. A recent analysis of 24 studies incorporating synchronous chat/ text found that this is acceptable and feasible as a mode of therapeutic support, with most studies demonstrating improved outcomes compared to waitlist control groups and equivalence to treatment as usual (face-to-face in most studies). In addition, participants in some studies indicated a preference for this mode of interaction over telephone call (Hoermann, Mccabe, Milne, & Calvo, 2017) . In the genetic counseling space, companies like Clear Genetics (www.cleargenetics.com) are integrating chatbots to offer intelligent responses to patient questions as they review test options and collect information in preparation for an appointment with a healthcare provider, such as a genetic counselor.
Similarly, NIH-funded projects like www.itrunsinmyfamily.com use chatbots to create an interactive environment through which to construct pedigrees, collect personal health information, and produce a risk assessment.
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Commercial genetic testing laboratories, such as GeneDx and Blueprint Genetics, already integrate AI into their bioinformatics pipelines to help with analyzing complex phenotypes, assessing genomic variants, classifying novel genomic findings, and managing test utilization.
Genetic counselors are therefore increasingly encountering genomic test results that have been determined, in part, with AI-driven technology if the laboratory they are utilizing has implemented it into their pipeline.
| Risk assessment and decision support tools
Even in the most straightforward cases, risk assessment in genetic counseling is a two-step process: gathering family history information and using that information to calculate the likelihood of an event occurring. From the man at 50% risk to develop Huntington's disease based on his mother's diagnosis, to the patient with a 7.3% likelihood to have a BRCA1 mutation based on BRCAPro, genetics clinicians rely heavily on numbers to provide information and context for patients to understand their personal risk. In traditional models, accurate risk assessment is vulnerable at several steps throughout the process due to insufficient family history information collected by healthcare providers, failure to identify risk factors, lack of referral for genetics evaluations, and inconsistent management of families at increased familial risk of cancer (Niendorf et al., 2016) .
Each of the vulnerabilities in the patient assessment process can be addressed with today's risk assessment tools. As we described, use of risk assessment algorithms is not new-but the interface, automation, and sophistication of these tools continues to evolve. Several risk assessment tools allow providers to email a link to a patient, through which they can enter a user-friendly interface, provide personal and family health information, generate a risk assessment, and have it emailed back to the provider and the patient before the visit. These tools reduce the time providers spend on family history collection and in some cases, enable non-genetics providers to collect this information during a visit when it otherwise would not have occurred due to competing priorities (e.g. CDC's Family Healthware TM , Duke's MeTree, Intermountain Healthcare's OurFamilyTree, Cleveland Clinic's MyFamily, CancerGeneConnect). In some cases (www.itrunsinmyfamily.com), these tools will, with the permission of the user, connect family members to invite them to provide additional information. Others can, at the direction of a genetic counselor or other qualified healthcare provider, autogenerate insurance preauthorization letters and forms, patient documentation, and track patients and their samples for needed follow-up (e.g. www.cancerIQ.com).
Risk assessment helps identify patients at elevated risk, so clinical decision support can be engaged to help develop a personalized care plan for those individuals. Welch and Kawamoto (2013) conducted a systematic analysis of clinical decision support tools and found 38 articles published between 1990 and 2011 focused on genetically guided personalized medicine. While many of these articles described and assessed the risk assessment tools described above, some were directed toward integration of management guidelines for cancer and other conditions into clinical care, pharmacogenomic-driven decision support, and risk assessment for conditions other than cancers.
Although many of the studies included in this analysis established the utility of their approach, the challenge, identified by Welsh and Kawamoto, was that of integrating genomic data into the electronic health record for easy access and utility in the clinical workflow. This is a technological challenge we continue to face today.
Despite limitations, integrating technology for recording family history and assessing risk has the potential to increase efficiency and consistency in clinical practice, and improve identification of at-risk individuals. Doerr, Edelman, Gabitzsch, Eng, and Teng (2014) , in their assessment of Cleveland Clinic's MyFamily, found that providers included in the study believed the MyFamily risk assessment tool would, "increase the quality and consistency of care received by patients, appropriately flagging those at high risk for additional screening/referral, more in-depth/targeted counseling, facilitating a personalized approach to risk management and allowing for appropriate reassurance of the 'worried well'" (p. 128).
| U S I NG TE CH NOL OGY TO OP TI M I ZE GE NE TI C C OU NS E LO R R EF E RR A LS A N D P RA CT IC ES
In the typical genetic counseling practice, no matter what specialty, some patients arrive for genetic counseling without a clear reason for referral or objective elevated risk for a genetic condition or predisposition. The patients may be halfheartedly seeking genetic counseling in an effort to be compliant to physician recommendations (the basis for which may have been unstated or misunderstood) or they may have an elevated impression of their genetic risk (Bellcross et al., 2015) . In a perfect world, more patients would present with a strong medical indication and realistic impression of their risk.
One of the best ways to increase appropriate referrals of patients who need more personalized risk assessments, genetic counseling, and care is education of providers and patients. Video learning and interactive e-learning modules can help serve as virtual assistants and educators offering a baseline level of standardized content that may help reduce the number of inappropriate patient referrals. The utility of these virtual genetic education aids, including videos and interactive e-learning programs, has been validated across multiple patient popula- Beyond education solutions, healthcare providers may also find that many technological tools discussed previously including risk assessment, algorithm-based diagnostic aids, and interactive educational tools, can help optimize referrals to genetic counselors and help them prepare patients for the session. Self-service consumer-and patient-focused technology solutions are now also available outside of the typical clinical setting. These technological solutions may offer a specific answer that results in the genetic counselor seeing a patient with a higher level of genetic knowledge, who will benefit from the more personalized care and attention of a genetic counselor; it may also identify where the need for genetic counseling could be decreased or eliminated for some individuals.
There are several examples of self-service consumer-and patientfocused technology solutions already in use. These include commercial laboratory websites (such as Counsyl, Color Genomics, Invitae, and others) as well as research studies (such as my46 and the Coriell Personalized Medicine Collaborative), which provide educational modules online and make results available directly to patients with live (phone) and recorded video support as well as written educational content.
These tools (and others like them) were born out of the recognition that while it is very important that patients understand the risks, benefits, and limitations of genetic testing, a well-designed, genetic counselor-informed interactive educational tool often meets that need and may decrease the need for many patients at lower risk to see a genetic counselor in person. Tools that meet basic patient needs have the potential to increase access to genetic counseling for those patients with a higher level of need, such as in the event of a change in risk status (e.g., patients learning that they are carriers for cystic fibrosis, which may prompt genetic counseling) (Grinzaid et 
| F U TU RE D I RE CTI ON S
The genetics community is still learning how best to integrate technological solutions to help patients, consumers, providers, and genetic counselors, but the future looks interesting and innovative. The opportunity to help genetic clinicians reach appropriate patients, consumers, and healthcare providers access accurate and up-to-date information about genetics, genetic testing, and disease management in a way that closes existing gaps is exciting. Technological innovations can help genetic counseling stay current in an increasingly digital world and increasingly tech-savvy families (Wade & Elliott, 2017) .
Imagine technology integrated into primary care EMR systems that efficiently identify patients at risk for a hereditary disease based on key indicators (e.g. family history, age of onset). This could also be a patient-driven process, with intake information that families provide
being merged with what is found in the EMR. That same system could then present the primary care provider with recommended referrals to available local genetics and telegenetics clinics based on patient need and insurance. Patients could then schedule their appointments, and at the same time be prompted to complete an online family history collection and risk assessment prior to the appointment, if not already done.
The same system could provide informational, educational videos before the appointment so the patient knows what to expect.
During the appointment, the clinician would be able to focus on assessing and discussing previously gathered patient risk information, The above scenario, in Figure 1 , which started with a patient with an indication for a genetics referral, identified in the primary care setting, would have likely been missed using current approaches to patient identification (Bellcross et al., 2015; Childers, Childers, MaggardGibbons, & Macinko, 2017) . Adopting the futuristic workflow above will lead genetic counselors to a time where patients are appropriately identified and referred in a timely manner, and efficiencies in the system allow for the growing genetics workforce to meet patient needs.
All of the pieces of these technological applications are available in some way (with varied levels of maturity) and it is only a matter of time until they have fully evolved and most importantly, been integrated across health systems.
Going one step further, imagine a future where genetics is integrated into routine screening early in life, stored, and unlocked throughout the lifetime as needed. Just as so many aspects of medicine are triggered by age or other variables, an individual's genome could be queried throughout their lifetime, integrated into EMRs, supported by decision support tools, with educational material automatically sent to patients and healthcare providers prior to the visit (Figure 1 ).
In addition to genetic information becoming more "routine", we will likely continue to see a movement toward healthcare driven by patients. Patients are increasingly going online to seek medical information. According to the Pew Research Center, six in ten internet users search online for health information (Remez, 2013) . Among those using the internet for health information, there is a higher number of individuals with one or more chronic conditions (Fox & Duggan, 2013a) .
The patient engagement movement refers not only to seeking answers in the form of content, but in data as well. One survey of the U.S. population found that 69% of adult Americans tracks at least one data point about themselves (weight, diet, exercise) (Fox & Duggan, 2013b (Simmons, Wolever, Bechard, & Snyderman, 2014) .
Over the next few years, we will likely see this trend continue with increasing demand for information and increased control over all data, including genetic data, as evidenced by the emergence of companies like Luna DNA (www.lunadna.com), in which patients own, control and have the option to broker the use of their DNA-based data.
| C HA L LE NG ES
Challenges to integrating technological solutions into medical genetics and genetic counseling come in two main categories: discipline-specific and technology-specific. The discipline-specific challenges revolve around resistance to using technology in counseling, fear of the unknown, and concerns that technology will eliminate or decrease the need for genetic counselors and/or genetic counseling, or reduce its
quality. An illustrative situational parallel can be seen in the original concerns that genetic counselors and other genetics professionals had about DTC genetic testing (Harris, Kelly, & Wyatt, 2013) . Initially, the concept of genetic testing that a consumer could order independent of a healthcare provider seemed dangerous and certain to lead to consumer harm. Although the availability of certain types of DTC testing has been limited by law, the adoption and comfort of genetic counselors with DTC testing has increased, and evidence of harm is lacking (Covolo, Rubinelli, Ceretti, & Gelatti, 2015; Roberts & Ostergren, 2013 ).
Technological innovations now face a similar time in which they need to prove their worth and lasting impact before they will be integrated into practices. Although genetic counselors are lifelong learners, well-versed in the need and ability to adapt to a growing knowledge base, the initial training time and brain power investment in learning to use new tools may not, at first, seem to justify the time savings. In addition, some genetic counselors may be concerned that using technology to educate and interact with patients and healthcare providers could decrease the need for genetic counselors. More specifically, if other healthcare professionals are able to access technological tools and provide genetic counseling to their patients, or patients can do it themselves with an educational program, will that not decrease the need for genetic counselors (Wilkes et al., 2017) ? In addition to those practical concerns, there is also a human concern that the very personalized, and needs, but unfortunately do not interact or integrate with each other. One technological approach focuses on helping healthcare providers find labs that offer the required genetic testing at the best price, while another may offer disease-specific information for patients-but only those with a predisposition to breast and ovarian cancer, not colorectal cancer. The decentralized nature of these solutions suggests that one challenge to overcome is combining technology into broader, more seamless, solutions that move smoothly from patient to provider to lab to genetic counselor to patient. Another challenge is navigating the regulatory waters that protect patient privacy and rights, while making sure that they are not harmed by incorrect information provided by inexperienced or poorly designed applications.
| CON CL U S I ON
There is no doubt that a technological boom has occurred over the last few years that already has, and will continue, to significantly impact the practice of genetic counseling. As described above, there are real challenges to adoption. However, the question is not what can be done to overcome these challenges but rather, how we as a profession can embrace these challenges. We have the opportunity to look past the challenges to the promise. We also have the expertise and key insights to shape the technology itself, which will help invest us into the process of development and adoption.
That is not to say that emerging technologies promising efficiency may not first be more time-consuming, or even that they will meet every promise, but technology often comes in baby steps. Change is challenging at first. We adopted the flip phone followed by the smartphone, and we did not reject either due to the complexity or the fact that they were not the perfect solution. Maybe more important than the willingness to try new technology is the need for all of us to have the confidence in the value offered by genetic counselors that developing and adopting technology will not make us obsolete or diminish our value-it will elevate us. Technology has the potential to make us more efficient, eliminate or reduce tasks that do not necessitate our expertise, and allow us to spend more time on activities that require specialized training, interpersonal interaction, and ultimately add value.
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